WA
VTAK icon

Wasatch Advisors’s Catheter Precision VTAK Stock Holding History

Wasatch Advisors’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1
Closed -$585K – 249
2019
Q2 		$585K Hold
1
– – 0.01% 233
2019
Q1 		$816K Hold
1
– – 0.01% 222
2018
Q4 		$1.64M Buy
+1
New +$2.36M 0.02% 215
2018
Q3 		– Hold
0
– – – 220

Other funds holding VTAK

Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BLAM
Bourne Lent Asset Management Pawling, New York $272M AUM 30.95% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
WC
Weil Company San Diego, California $445M AUM 14.95% 1-Year Est. Return

Wasatch Advisors's VTAK Position: Q3 2019 in Review

Wasatch Advisors sold out of Catheter Precision (VTAK) in Q3 2019, closing a stake of 1 share — an estimated $585K sold.

Wasatch Advisors first reported a position in VTAK in Q4 2018 and held it in 3 quarters. The position peaked at $1.64M in Q4 2018. 5 funds tracked by Wall St. Rank hold VTAK as of Q3 2019.

  • Wasatch Advisors reported no remaining Catheter Precision position as of Q3 2019 after selling out during the quarter.
  • Wasatch Advisors sold 1 Catheter Precision share in Q3 2019, an estimated $585K.
  • Wasatch Advisors first reported a position in Catheter Precision in Q4 2018 and held it in 3 quarters.
  • Wasatch Advisors's Catheter Precision position peaked at $1.64M in Q4 2018.
  • 5 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2019.

Based on Wasatch Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.